×
21.09.2023 · BRCA1- and BRCA2-associated hereditary breast and ovarian cancer (HBOC) is characterized by an increased risk for female and male breast ...
Es fehlt: gabriele. | Suchen mit:gabriele.
Weitere Fragen
An official website of the United States government ... A service of the National Library of Medicine, National ... Available from: https://www.ncbi.nlm.nih.gov/ ...
Es fehlt: gabriele. q=
Abbreviations: BRCA=breast cancer susceptibility gene; BRCAPRO=breast cancer susceptibility gene prediction model; BOADICEA=Breast and Ovarian Analysis of ...
Myriad Genetics' long-time monopoly on BRCA gene testing was significantly narrowed by the Supreme Court's decision in AMP v. Myriad Genetics, Inc.
This report is based on research conducted by the Pacific Northwest Evidence-based Practice. Center (EPC) under contract to the Agency for Healthcare ...
MicroRNA (miRNA or miR) are small non-coding RNA molecules that have an essential role in gene expression and are significantly linked to tumor development and ...
03.03.2023 · Evidence-based, expert-reviewed summary about the BRCA1 and BRCA2 genes and hereditary breast and ovarian cancer. This summary also contains ...
Es fehlt: gabriele. NBK1247/
04.01.2023 · This practice resource intends to provide guidance for genetic counselors and other healthcare providers caring for adults seeking pre- or post- ...
Myriad Genetics' long-time monopoly on BRCA gene testing was significantly narrowed by the Supreme Court's decision in AMP v. Myriad Genetics, Inc.
18.08.2020 · https://www.cancer.gov/about-cancer/causes- ... de Koning et al. N Engl J Med. 2020 382:503. Page 43 ... https://www.ncbi.nlm.nih.gov/books/NBK1247/ ...